- Bermejo, M., Camara-Martinez, I., Sanchez-Dengra, B., Ruiz-Picazo, A., Gonzalez-Alvarez, I. and Gonzalez-Alvarez, M., 2024. In silico, in situ, in vitro, and in vivo predictive methods for modeling formulation performance. In From Current to Future Trends in Pharmaceutical Technology (pp. 67-116). Academic Press.
- Eales, B.M., 2024. Novel Therapy for Acinetobacter baumannii Infections (Doctoral dissertation).
- Garcia, E., Diep, J.K., Sharma, R. and Rao, G.G., 2024. Model-based learn and confirm: designing effective treatment regimens against multidrug resistant Gram-negative pathogens. International Journal of Antimicrobial Agents, 63(4), p.107100.
- Parhiz, H., Shuvaev, V.V., Li, Q., Papp, T.E., Akyianu, A.A., Shi, R., Yadegari, A., Shahnawaz, H., Semple, S.C., Mui, B.L. and Weissman, D., 2024. Physiologically-based modeling of LNP-mediated delivery of mRNA in the vascular system. Molecular Therapy-Nucleic Acids.
- Singh, S., Gumbo, T., Boorgula, G.D., Thomas, T.A., Philley, J.V. and Srivastava, S., 2024. Omadacycline pharmacokinetics/pharmacodynamics and efficacy against multidrug-resistant Mycobacterium tuberculosis in the hollow fiber system model. Antimicrobial Agents and Chemotherapy, 68(2), pp.e01080-23.
- Staudt, K.J., Olivo, L.B., Alves, I.A. and Araújo, B.V.D., 2024. The role of modeling and simulation to improve the treatment of fungal infections caused by Cryptococcus: A literature review. Brazilian Journal of Pharmaceutical Sciences, 60, p.e23446.
- Vasić, V., Gustafsson, J., Nowshahr, E.Y., Stenvall, A., Beer, A.J., Gleisner, K.S. and Glatting, G., 2024. A PBPK model for PRRT with [177Lu] Lu-DOTA-TATE: Comparison of model implementations in SAAM II and MATLAB/SimBiology. Physica Medica, 119, p.103299.
- Wang, J., Chen, T., Ruszaj, D.M., Mager, D.E. and Straubinger, R.M., 2024. Integrated PK/PD Modeling Relates Smoothened Inhibitor Biomarkers to The Heterogeneous Intratumor Disposition of Cetuximab in Pancreatic Cancer Tumor Models. Journal of Pharmaceutical Sciences, 113(1), pp.72-84.
- Zhang, L., Kagan, L., Rowland, M. and Mager, D.E., 2024. Target Reserve and Turnover Parameters Determine Rightward Shift of Enalaprilat Potency From its Binding Affinity to the Angiotensin Converting Enzyme. Journal of Pharmaceutical Sciences, 113(1), pp.167-175.